MARGARET BOBONICH: Open Payments
NPI 1821143066 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,132 in 57 payments from 11 companies in 2025. Trend: 2023 $87,790 · 2024 $50,248 · 2025 $19,132
Speaker / faculty: $6,466Honoraria: $4,185Consulting: $3,330Travel & lodging: $3,075Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 28 | $9,341 |
| Organon LLC | 10 | $5,490 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,000 |
| UCB, Inc. | 2 | $1,376 |
| Janssen Biotech, Inc. | 4 | $265 |
| LEO Pharma Inc. | 1 | $149 |
| Amgen Inc. | 2 | $142 |
| E.R. Squibb & Sons, L.L.C. | 3 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $141 |
| GENZYME CORPORATION | 1 | $61 |
Products named: DUPIXENT, VTAMA, Bimzelx, TREMFYA, ANZUPGO, OTEZLA, Sotyktu, Rhapsido.
Industry payments across OH — which companies pay providers there.
